Non-Sterile Compounding Pharmacy Market Companies: Size, Trends, and Forecast (2025–2034)

By /

The non-sterile compounding pharmacy market is witnessing remarkable growth, driven by the increasing demand for personalized medicine and advances in pharmaceutical formulation techniques. Estimated at US$ 5.97 billion in 2024, it is projected to grow to US$ 6.41 billion in 2025 and reach approximately US$ 12.11 billion by 2034, expanding at a CAGR of 7.34% between 2025 and 2034.

With applications spanning dermatology, hormonal therapies, and beyond, compounded pharmaceuticals are reshaping patient care globally. Let’s dive into key trends, regional insights, and a spotlight on leading companies in the non-sterile compounding pharmacy market.

📈 Market Overview

  • Market Size (2024): US$ 5.97 Billion

  • Market Size (2025): US$ 6.41 Billion

  • Forecast (2034): US$ 12.11 Billion

  • CAGR (2025–2034): 7.34%

🔥 Key Drivers

  • Rising preference for customized medicines over commercial alternatives.

  • Growth in dermatology and hormonal replacement therapies.

  • Innovations in delivery systems for improved patient adherence.

🌍 Regional Insights

  • North America led with a market share of 48–52% in 2024.

  • Asia Pacific expected to post the fastest CAGR during 2025–2034.

💊 Segmental Insights

  • Oral Solids dominated with 35–38% market share in 2024.

  • Topicals are forecast to grow at the highest CAGR.

  • Hormonal Replacement Therapy (HRT) was the leading therapeutic area in 2024, contributing 30–35% revenue.

🌟 Top Companies in the Non-Sterile Compounding Pharmacy Market

Here’s a closer look at the major players shaping the non-sterile compounding pharmacy market, including their background, offerings, and market positioning.

1️⃣ Advanced Pharmacy

  • About: Based in Texas, Advanced Pharmacy is a leading compounding pharmacy offering personalized medications for pain management, dermatology, and veterinary needs.

  • Products: Oral solutions, creams, transdermal gels.

  • Market Cap: Estimated mid-size player with strong regional presence in North America.

2️⃣ Avella Specialty Pharmacy

  • About: Avella is renowned for its specialty and compounding services, with a focus on oncology, dermatology, and ophthalmology.

  • Products: Topical preparations, injectables, and hormone therapies.

  • Market Cap: Part of UnitedHealth Group after acquisition, contributing to a multibillion-dollar network.

3️⃣ BCP (Belmar Pharma Solutions)

  • About: BCP specializes in bioidentical hormone replacement therapy (BHRT) and custom compounding services across the U.S.

  • Products: Capsules, troches, topical creams.

  • Market Cap: Privately held, but among the top-tier compounding service providers.

4️⃣ CareFirst Specialty Pharmacy

  • About: Serving both humans and pets, CareFirst is known for its advanced compounding labs and quality control.

  • Products: Oral suspensions, suppositories, transdermal patches.

  • Market Cap: Emerging regional player with growing influence.

5️⃣ Central Compounding Center

  • About: Central Compounding Center caters to physicians and patients seeking high-quality custom formulations.

  • Products: Dermatology creams, hormone replacement capsules, veterinary compounds.

  • Market Cap: Small but rapidly expanding footprint in the Midwest U.S.

6️⃣ Cipla Medpro (Compounding Division)

  • About: A division of Cipla Limited, Cipla Medpro offers non-sterile compounding solutions in South Africa and beyond.

  • Products: Topical dermatological formulations, oral liquids.

  • Market Cap: Part of Cipla’s global valuation exceeding US$ 10 billion.

7️⃣ Clinigen Group

  • About: Clinigen provides unlicensed medicines and compounding services, addressing niche therapeutic needs.

  • Products: Custom oral and topical formulations.

  • Market Cap: Approx. £1 billion (private after acquisition by Triton).

8️⃣ Columbia Veterinary Pharmacy

  • About: Specializes in veterinary compounding, serving both small and large animals.

  • Products: Flavored oral suspensions, transdermal gels for pets.

  • Market Cap: Niche player with steady growth in veterinary segment.

9️⃣ Fagron

  • About: A global leader in pharmaceutical compounding with operations in over 30 countries.

  • Products: Dermatology creams, oral suspensions, personalized medicine kits.

  • Market Cap: Approx. €1.6 billion.

1️⃣0️⃣ Innovation Compounding

  • About: Focuses on wellness and anti-aging formulations alongside traditional compounding services.

  • Products: BHRT, dermatology, pediatric formulations.

  • Market Cap: Leading independent U.S. pharmacy.

1️⃣1️⃣ ITC Compounding Pharmacy

  • About: Known for hormone therapy and dermatological formulations tailored to individual patient needs.

  • Products: Oral capsules, topical gels, sublingual tablets.

  • Market Cap: Mid-size U.S. player with a strong patient base.

1️⃣2️⃣ Letco Medical

  • About: Supplies high-quality APIs and excipients for compounding pharmacies, alongside their own compounding services.

  • Products: Customizable non-sterile medication kits.

  • Market Cap: Significant supplier network in North America.

1️⃣3️⃣ Medisca

  • About: A global supplier of pharmaceutical compounding products and equipment.

  • Products: Oral solutions, dermatological creams, veterinary formulations.

  • Market Cap: Large-scale global operations, privately held.

1️⃣4️⃣ National Custom Compounding

  • About: Australian pharmacy specializing in customized medications for dermatology and sports medicine.

  • Products: Capsules, creams, oral liquids.

  • Market Cap: Prominent in Oceania’s compounding market.

1️⃣5️⃣ Pencol Compounding Pharmacy

  • About: Offers innovative compounding solutions focusing on patient-specific therapies.

  • Products: Transdermal creams, oral suspensions, pediatric formulations.

  • Market Cap: Small yet growing U.S. player.

1️⃣6️⃣ PCCA (Professional Compounding Centers of America)

  • About: PCCA is a global supplier supporting compounding pharmacies with ingredients, education, and training.

  • Products: APIs, excipients, equipment for pharmacies.

  • Market Cap: Integral to compounding infrastructure worldwide.

1️⃣7️⃣ PharmScript

  • About: Provides pharmacy services to long-term care facilities including non-sterile compounding.

  • Products: Oral tablets, topical solutions for institutional use.

  • Market Cap: Mid-size U.S. pharmacy with a focus on institutional healthcare.

Request a customized case study tailored to your business needs and gain deeper insights
into healthcare market strategies: sales@towardshealthcare.com

❓ FAQs About the Non-Sterile Compounding Pharmacy Market

Q1: What is driving the growth of the non-sterile compounding pharmacy market?
A1: Growing demand for personalized medicine, advancements in compounding technologies, and rising prevalence of chronic diseases.

Q2: Which region dominates the global market?
A2: North America held the largest market share in 2024, driven by advanced healthcare infrastructure and regulatory support.

Q3: Which dosage form leads the market?
A3: Oral solids accounted for the largest market share in 2024, while topicals are expected to grow fastest.

Q4: What are some emerging trends in this market?
A4: Increased use of automation in compounding, growth of veterinary compounding, and a focus on anti-aging formulations.

Q5: Who are the key players in the market?
A5: Major companies include Fagron, Medisca, PCCA, Avella Specialty Pharmacy, and Advanced Pharmacy.

Source : https://www.towardshealthcare.com/insights/non-sterile-compounding-pharmacy-market-sizing

Invest in Our Premium Strategic Solution: https://www.towardshealthcare.com/price/5864

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top